🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Pantera Capital Partners - Q4 2025 13F Filings

PA

Pantera Capital Partners Lp

CIK: 0002067181
Address: California San Francisco 600 Montgomery Street, 45Th Floor
$229.24 M
Portfolio Value
20
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 02/27/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Sells

Q4 2025
3. Helius Med Technologies
−$57.88 M

Asset Allocation

Stocks/ETFs
-70.87%
$228.87 M 99.83%
Options
$0 0.00%
Debt
$0 0.00%
Other
+100.00%
$378,790 0.17%

Sector Allocation (Stocks)

Pantera Capital Partners Q4 2025 Filing Summary

Pantera Capital Partners Lp originally filed its 13F report for Q4 2025 on February 17, 2026. The filing was subsequently amended, with the latest update submitted on February 27, 2026. The portfolio totaled 229.24 M reflecting a -70.83% change from the prior quarter, spanning 20 assets. The top 10 holdings comprised 92.9% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 5 new positions and 8 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Pantera Capital Partners’s Q4 2025 Filing

Yes. Pantera Capital Partners originally filed on 02/17/2026 and subsequently submitted 1 amendment(s). The latest filing (13F-HR/A) was submitted on 02/27/2026.

In the Q4 2025 filing, Pantera Capital Partners reported a managed portfolio value of 164.21 M, consisting of 15 individual positions.

Multiple filings indicate that Pantera Capital Partners updated their Q4 2025 report. The initial filing was submitted on 02/17/2026, followed by amendments to correct data or disclose previously confidential holdings.

This page displays the raw filing documents. To see which stocks Pantera Capital Partners bought or sold during Q4 2025, please visit Pantera Capital Partners's Portfolio Analysis page.